Influenza challenge successfully completed
For the proof-of-principle, influenza A/PR/8/34 VLPs carrying four parental proteins were tested in a mouse challenge model. Final results show that Redbiotec’s influenza-VLPs effectively protect the immunized mice against the parental challenge virus. Please contact Redbiotec (raehle@redbiotec.ch) for more information to these study results.
Redbiotec signs exploratory study with Intercell AG
Redbiotec has entered into a cooperation with Intercell AG (Vienna, Austria), in which Redbiotec will apply its proprietary technology platform rePAX™ to an undisclosed discovery area. Check Redbiotec news site for more information.
Restorm, a Zurich based social media platform for bands and rightclearing platform for art buyers, secured a financing round with Cantonal Bank of Zurich ZKB and Redalpine. As a novel disruptive business model Redalpine’s portfolio company launches rightclearing for art buyers in industries such as advertising, TV, movies and gaming. Art buyers will be able to search, listen to and license music by mood, genre, sound-alikes or sociodemographic criteria of the respective fans.
Questli, provider of crowd-sourced smartphone quests, secured a 
In September the ETH Spinoff Malcisbo Ltd. has successfully closed its seed financing round. The initial target of CHF 2.4 Mio. was substantially exceeded. Private investors, Business Angels, Zürcher Kantonalbank Startup Finance and Redalpine Venture Partners AG have invested in total a sum of CHF 3.6 Mio in the company. In parallel the company was granted a substantial research contribution by CTI. 